Low-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome

被引:169
作者
Valle, M
Martos, R
Gascón, F
Cañete, R
Zafra, MA
Morales, R
机构
[1] Valle Pedroches Hosp, Dept Pediat, Clin Lab Dept, Cordoba, Spain
[2] Basic Hlth Zone Pozoblanco Cordoba, Cordoba, Spain
[3] Reina Sofia Hosp, Dept Pediat, Cordoba, Spain
关键词
C-reactive protein; obesity; children; metabolic syndrome; cardiovascular risk;
D O I
10.1016/S1262-3636(07)70167-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the concentration levels of C-reactive protein (CRP), leptin and adiponectin in obese pre-pubertal children, and their possible relation with metabolic syndrome, fibrinogen and plasminogen activator inhibitor-1. Methods: A study was carried out in 51 obese children (aged 6 to 9 years) and the same number of non-obese children (control group), matched by age and sex. (Cross-sectional study of obese children). Body mass index (BMI), waist/hip ratio (WHR) and blood pressure were determined for each child. Serum CRP, leptin, adiponectin, glucose, insulin, lipid profile, plasminogen activator inhibitor-1 (PAI-1) and fibrinogen were all measured. Results: The levels of CRP serum (1.67 +/- 0.222 vs 0.92 +/- 0.16 mg/1) and leptin (15.56 +/- 1.27 vs 4.68 +/- 0.62 ng/ml) were significantly higher in obese children. The adiponectin level was significantly higher in non-obese children (11.58 +/- 0.63 vs 9.64 +/- 0.49 mug/dl). In the obese group, log. CRP showed a positive correlation with BMI, insulin, homeostasis model assessment (HOMA), triglycerides, alanine aminotransferase (ALT), uric acid, PAI-1, fibrinogen and interleukin 6 (IL-6), and correlated negatively with apolipoprotein A-I and high-density lipoprotein cholesterol (HDL-C). The leptin was positively correlated with BMI, insulin, HOMA, triglycerides and PAI-1 and negatively with Apo A-I and HDL-C. Adiponectin correlated negatively with BMI, insulin, HOMA, and triglycerides. Conclusions: Low-grade systemic inflammation, elevated leptin concentration and low adiponectin level are described in very young obese children, correlating with a range of variables of metabolic syndrome. Inflammation and adipocytokines can play an important role in the etiopathogeny of metabolic syndrome.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 49 条
[1]  
Bastard JP, 2000, DIABETES-METAB RES, V16, P192, DOI 10.1002/1520-7560(200005/06)16:3<192::AID-DMRR114>3.0.CO
[2]  
2-G
[3]   Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels [J].
Böttner, A ;
Kratzsch, J ;
Müller, G ;
Kapellen, TM ;
Blüher, S ;
Keller, E ;
Blüher, M ;
Kiess, W .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) :4053-4061
[4]   C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors [J].
Cook, DG ;
Mendall, MA ;
Whincup, PH ;
Carey, IM ;
Ballam, L ;
Morris, JE ;
Miller, GJ ;
Strachan, DP .
ATHEROSCLEROSIS, 2000, 149 (01) :139-150
[5]   Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells [J].
Crichton, MB ;
Nichols, JE ;
Zhao, Y ;
Bulun, SE ;
Simpson, ER .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 118 (1-2) :215-220
[6]   Presence of metabolic cardiovascular syndrome in obese children [J].
Csábi, G ;
Török, K ;
Jeges, S ;
Molnár, D .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (1-2) :91-94
[7]   Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Gallimore, JR ;
Pepys, MB .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204
[8]   C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease [J].
Danesh, J ;
Wheeler, JG ;
Hirschfield, GM ;
Eda, S ;
Eiriksdottir, G ;
Rumley, A ;
Lowe, GDO ;
Pepys, MB ;
Gudnason, V .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (14) :1387-1397
[9]  
deCourten M, 1997, DIABETIC MED, V14, P200, DOI 10.1002/(SICI)1096-9136(199703)14:3<200::AID-DIA336>3.0.CO
[10]  
2-V